First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer Data from demographics, survival, diagnoses codes, procedure codes, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback